Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment

Conventional cancer chemotherapies often exhibit insufficient therapeutic outcomes and dose-limiting toxicity. Therefore, there is a need for novel therapeutics and formulations with higher efficacy, improved safety, and more favorable toxicological profiles. This has promoted the development of nan...

Descripción completa

Detalles Bibliográficos
Autores principales: Entzian, Kristin, Aigner, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397943/
https://www.ncbi.nlm.nih.gov/pubmed/34452096
http://dx.doi.org/10.3390/pharmaceutics13081135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397943/
https://www.ncbi.nlm.nih.gov/pubmed/34452096
http://dx.doi.org/10.3390/pharmaceutics13081135

Ejemplares similares